TipRanks
Go Ultimate55% OFF

Health In Tech, Inc. Class A (HIT) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

HIT Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to Health In Tech, Inc. Class A in the past 3 months

HIT Stock 12 Month Forecast

$2.63▲(354.94% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Health In Tech, Inc. Class A in the last 3 months. The average price target is $2.63 with a high forecast of $4.00 and a low forecast of $1.25. The average price target represents a 354.94% change from the last price of $0.58.
Highest Price Target$4.00Average Price Target$2.63Lowest Price Target$1.25

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for HIT
Price TargetFollowArticle
Maxim Group$3→$1.25buy116.64%UpsideReiterated10/02/26
Craig-Hallum$4buy593.24%UpsideReiterated10/01/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Health In Tech, Inc. Class A

3 Months
Allen Klee
Allen KleeMaxim Group
Success Rate3/8 ratings generated profit
38%
Average Return
+38.00%

Copying Allen Klee's trades and holding each position for 3 Months would result in 37.50% of your transactions generating a profit, with an average return of +38.00% per trade.

1 Year
Allen Klee
Allen KleeMaxim Group
Success Rate1/8 ratings generated profit
13%
Average Return
-34.74%

Copying Allen Klee's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -34.74% per trade.

2 Years
George Sutton
George SuttonCraig-Hallum
Success Rate0/4 ratings generated profit
0%
Average Return
-41.48%

Copying George Sutton's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -41.48% per trade.

HIT Analyst Recommendation Trends

02468Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for HIT
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy32224
Buy10000
Hold00000
Sell00000
Strong Sell00000
total42224

In the current month, HIT has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HIT average Analyst price target in the past 3 months is 2.63.

HIT Financial Forecast

$-2$-1.25$-0.5$0.25$1Q4 2025Q2 2026Q3 2026
High$-0.03
Consensus$-0.05
Low$-0.07

HIT Earnings Forecast

Next quarter’s earnings estimate for HIT is -$0.05 with a range of -$0.07 to -$0.03. The previous quarter’s EPS was -$0.04. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

$6.4M$7.5M$8.7M$9.8M$11MQ4 2025Q2 2026Q3 2026
High$11M
Consensus$7.96M
Low$6.37M

HIT Sales Forecast

Next quarter’s sales forecast for HIT is $7.96M with a range of $6.37M to $11.00M. The previous quarter’s sales results were $8.06M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

HIT Stock Forecast FAQ

What is HIT’s average 12-month price target, according to analysts?
Based on analyst ratings, Health In Tech, Inc. Class A’s 12-month average price target is $2.63.
What is HIT’s upside potential, based on the analysts’ average price target?
Health In Tech, Inc. Class A has 354.94% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HIT a Buy, Sell or Hold?
Health In Tech, Inc. Class A has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Health In Tech, Inc. Class A’s price target?
The average price target for Health In Tech, Inc. Class A is $2.63. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $4.00, the lowest forecast is $1.25. The average price target represents a 354.94% increase from the current price of $0.577.
What do analysts say about Health In Tech, Inc. Class A?
Health In Tech, Inc. Class A’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of HIT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.